Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Amneal Pharmaceuticals IncAMRX | $17.20 | Strong Buy | $23.00 | +33.72% | 19 hours ago | |
Analyst RankingTop 10% #514 out of 5323 analysts Average Return+15.74% Win Rate61%60 out of 98 Risk vs RewardPoor Good Analyst ColorUBS's Ashwani Verma raised their price target on Amneal Pharmaceuticals (NASDAQ: AMRX) by 21.1% from $19 to $23 on 2026/07/15. The analyst maintained their Strong Buy rating on the stock. Amneal Pharmaceuticals will report its Q2 2026 earnings on 2026/07/30. Raising their price target in a preview note, Verma predicted that Crexont and Women's Health will have driven growth, and that lanreotide's launch momentum will return "positive" guidance from management. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.